Clinical outcomes of radiotherapy as initial local therapy for Graves' ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgery

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Prabhu, Roshan S ^a,b   Liebman, Lang ^c   Wojno, Ted ^b   Hayek, Brent ^b   Hall, William A ^a,b   Crocker, Ian ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c Radiation Oncology Associates   (United States)

Author keywords

Graves' disease; Graves' ophthalmopathy; Graves' orbitopathy; Orbital radiation; Radiation therapy

Indexed keywords

STEROID;

ADULT; AGED; ARTICLE; CATARACT; DECOMPRESSION SURGERY; DIPLOPIA; DRUG DOSE REDUCTION; DRY EYE; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RADIATION DOSE; SOFT TISSUE; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DECOMPRESSION, SURGICAL; FEMALE; FOLLOW-UP STUDIES; GRAVES OPHTHALMOPATHY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84862275680     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-95     Document Type: Article

References (21)

1. Bahn RS. Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy. Thyroid: official journal of the American Thyroid Association 2002, 12:193-195.
2. Utiger RD. Pathogenesis of Graves' ophthalmopathy. N Engl J Med 1992, 326:1772-1773. 10.1056/NEJM199206253262610, 1375705.
3. Bartalena L, Marcocci C, Pinchera A. Graves' ophthalmopathy: a preventable disease?. European journal of endocrinology/European Federation of Endocrine Societies 2002, 146:457-461. 10.1530/eje.0.1460457, 11916611.
4. Bartalena L, Marcocci C, Tanda ML, Rocchi R, Mazzi B, Barbesino G, Pinchera A. Orbital radiotherapy for Graves' ophthalmopathy. Thyroid : official journal of the American Thyroid Association 2002, 12:245-250.
5. Prummel MF, Mourits MP, Blank L, Berghout A, Koornneef L, Wiersinga WM. Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet 1993, 342:949-954. 10.1016/0140-6736(93)92001-A, 8105213.
6. Bartalena L, Marcocci C, Chiovato L, Laddaga M, Lepri G, Andreani D, Cavallacci G, Baschieri L, Pinchera A. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab 1983, 56:1139-1144. 10.1210/jcem-56-6-1139, 6341388.
7. Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Lepri A, Pinchera A. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study. J Endocrinol Investig 1991, 14:853-860.
8. Werner SC. Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab 1977, 44:203-204. 10.1210/jcem-44-1-203, 576230.
9. Frueh BR. Why the NOSPECS classification of Graves' eye disease should be abandoned, with suggestions for the characterization of this disease. Thyroid: official journal of the American Thyroid Association 1992, 2:85-88.
10. Matthiesen C, Thompson JS, Thompson D, Farris B, Wilkes B, Ahmad S, Herman T, Bogardus C. The efficacy of radiation therapy in the treatment of Graves' orbitopathy. Int J Radiat Oncol Biol Phys 2012, 82:117-123. 10.1016/j.ijrobp.2010.08.053, 21030157.
11. Stiebel-Kalish H, Robenshtok E, Hasanreisoglu M, Ezrachi D, Shimon I, Leibovici L. Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis. J Clin Endocrinol Metab 2009, 94:2708-2716. 10.1210/jc.2009-0376, 19491222.
12. Prummel MF, Terwee CB, Gerding MN, Baldeschi L, Mourits MP, Blank L, Dekker FW, Wiersinga WM. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy. J Clin Endocrinol Metab 2004, 89:15-20. 10.1210/jc.2003-030809, 14715820.
13. Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Bergstralh EJ, et al. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology 2001, 108:1523-1534. 10.1016/S0161-6420(01)00632-7, 11535445.
14. Bradley EA, Gower EW, Bradley DJ, Meyer DR, Cahill KV, Custer PL, Holck DE, Woog JJ. Orbital radiation for graves ophthalmopathy: a report by the American Academy of Ophthalmology. Ophthalmology 2008, 115:398-409. 10.1016/j.ophtha.2007.10.028, 18082885.
15. Beckendorf V, Maalouf T, George JL, Bey P, Leclere J, Luporsi E. Place of radiotherapy in the treatment of Graves' orbitopathy. Int J Radiat Oncol Biol Phys 1999, 43:805-815. 10.1016/S0360-3016(98)00405-2, 10098436.
16. Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Buettner H, et al. The aftermath of orbital radiotherapy for graves' ophthalmopathy. Ophthalmology 2002, 109:2100-2107. 10.1016/S0161-6420(02)01293-9, 12414422.
17. Leong SC, White PS. Outcomes following surgical decompression for dysthyroid orbitopathy (Graves' disease). Current opinion in otolaryngology & head and neck surgery 2010, 18:37-43. 10.1097/MOO.0b013e328335017c, 22695626.
18. Baldeschi L, MacAndie K, Koetsier E, Blank LE, Wiersinga WM. The influence of previous orbital irradiation on the outcome of rehabilitative decompression surgery in graves orbitopathy. Am J Ophthalmol 2008, 145:534-540. 10.1016/j.ajo.2007.10.018, 18191092.
19. Bartalena L, Marcocci C, Tanda ML, Manetti L, Dell'Unto E, Bartolomei MP, Nardi M, Martino E, Pinchera A. Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med 1998, 129:632-635.
20. Perros P, Crombie AL, Kendall-Taylor P. Natural history of thyroid associated ophthalmopathy. Clin Endocrinol 1995, 42:45-50.
21. Broerse JJ, Snijders-Keilholz A, Jansen JT, Zoetelief J, Klein C, Seegenschmiedt MH. Assessment of a carcinogenic risk for treatment of Graves' ophthalmopathy in dependence on age and irradiation geometry. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology 1999, 53:205-208.